Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard F. Ambinder

Showing results (51-60 of 218) with videos related to

Pageof 22
Sort By:
AIDS (London, England)|April 25, 2022
Significance of lymph node fine needle aspiration for the diagnosis of HIV-associated lymphoma in a low-resource settingSamantha L Vogt, Lucia Maloma, Rena R Xian, et al.
Blood|January 9, 2016
The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseasesJennifer A Kanakry, Aparna M Hegde, Christine M Durand, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 10, 2021
Brief Report: Rebound HIV Viremia With Meningoencephalitis After Antiretroviral Therapy Interruption After Allogeneic Bone Marrow TransplantAdam A Capoferri, Andrew D Redd, Christopher D Gocke, et al.
Journal of Virology|July 26, 2019
Pharmacologic Activation of Lytic Epstein-Barr Virus Gene Expression without Virion ProductionJaeyeun Lee, John G Kosowicz, S Diane Hayward, et al.
Oncotarget|March 15, 2011
IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patientsJian He, Jian Wu, Yuchen Jiao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 19, 2009
Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphomaEllen T Chang, Brenda M Birmann, Julie L Kasperzyk, et al.
Leukemia & Lymphoma|October 30, 2004
Oral valacyclovir as prophylaxis against herpes simplex virus reactivation during high dose chemotherapy for leukemiaRobert Z Orlowski, Sharon R Mills, Eric E Hartley, et al.
Journal of Virology|June 2, 2017
Drug Modulators of B Cell Signaling Pathways and Epstein-Barr Virus Lytic ActivationJohn G Kosowicz, Jaeyeun Lee, Brandon Peiffer, et al.
Blood|May 26, 2005
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010Lawrence D Kaplan, Jeannette Y Lee, Richard F Ambinder, et al.
Journal of Medical Virology|September 13, 2002
Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's diseasePauline Meij, Marcel B H J Vervoort, Elisabeth Bloemena, et al.
Pageof 22

Showing results (51-60 of 218) with videos related to

Sort By:
Pageof 22
AIDS (London, England)|April 25, 2022
Significance of lymph node fine needle aspiration for the diagnosis of HIV-associated lymphoma in a low-resource settingSamantha L Vogt, Lucia Maloma, Rena R Xian, et al.
Blood|January 9, 2016
The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseasesJennifer A Kanakry, Aparna M Hegde, Christine M Durand, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 10, 2021
Brief Report: Rebound HIV Viremia With Meningoencephalitis After Antiretroviral Therapy Interruption After Allogeneic Bone Marrow TransplantAdam A Capoferri, Andrew D Redd, Christopher D Gocke, et al.
Journal of Virology|July 26, 2019
Pharmacologic Activation of Lytic Epstein-Barr Virus Gene Expression without Virion ProductionJaeyeun Lee, John G Kosowicz, S Diane Hayward, et al.
Oncotarget|March 15, 2011
IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patientsJian He, Jian Wu, Yuchen Jiao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 19, 2009
Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphomaEllen T Chang, Brenda M Birmann, Julie L Kasperzyk, et al.
Leukemia & Lymphoma|October 30, 2004
Oral valacyclovir as prophylaxis against herpes simplex virus reactivation during high dose chemotherapy for leukemiaRobert Z Orlowski, Sharon R Mills, Eric E Hartley, et al.
Journal of Virology|June 2, 2017
Drug Modulators of B Cell Signaling Pathways and Epstein-Barr Virus Lytic ActivationJohn G Kosowicz, Jaeyeun Lee, Brandon Peiffer, et al.
Blood|May 26, 2005
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010Lawrence D Kaplan, Jeannette Y Lee, Richard F Ambinder, et al.
Journal of Medical Virology|September 13, 2002
Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's diseasePauline Meij, Marcel B H J Vervoort, Elisabeth Bloemena, et al.
Pageof 22